Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Stereopure phosphoryl guanidine backbone chemistry increases the potency and durability of gene silencing by RNA interference

ABSTRACT: Stereopure phosphoryl guanidine backbone chemistry increases the potency and durability of gene silencing by RNA interference

PROVIDER: PRJNA910084 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR22574344.fastq.gz	Fastqsanger.gz
	SRR22574345.fastq.gz	Fastqsanger.gz
	SRR22574346.fastq.gz	Fastqsanger.gz
	SRR22574347.fastq.gz	Fastqsanger.gz
	SRR22574348.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 21

Similar Datasets

Stereopure phosphoryl guanidine backbone chemistry increases the potency and durability of gene silencing by RNA interference

Project description:To investigate the potential of "off target" of RNAi knockdown, primary mouse hepatocytes were treated with molecules targeting Ttr. We then performed gene expression profiling analysis using data obtained from RNA-seq of cell at two different doses along with an untreated control.

2023-05-25 | GSE220502 | GEO

Differentiational potency of induced pluripotent stem cells into cardiomyocytes

Project description:Transcriptional profiling of mouse induced pluripotent stem (iPS) cells with the low potency (strain 20D17) compared to control iPS cells with the normal potency (strain 38C2). Two-condition experiment: iPS cells strain 20D17 vs. control iPS cells strain 38C2. Biological replicates: 2 strain 20D17, 2 strain 38C2, independently grown and harvested. One replicate per array.

2010-06-23 | E-GEOD-18117 | biostudies-arrayexpress

Framework humanization increases the affinity and potency of anti-CD72 nanobody-based CAR-T cells for B-cell malignancies

Project description:Anti-CD19 CAR T cells can induce remissions in some patients with B-cell malignancies. However, new immunotherapeutic targets are urgently needed for the many who relapse. We recently described CD72 as a promising target in B-cell leukemia and lymphoma, developing fully synthetic nanobody-based CAR-T cells (nanoCARs) against this antigen. Toward clinical translation, here we humanize our previous nanobody framework regions, derived from llama, and surprisingly discover a clone ("H24") with enhanced potency against B-cell tumors both in vitro and in vivo. In vitro, H24 nanoCARs showed improved cytokine secretion and favorable immunophenotypic properties. RNA sequencing before and after tumor exposure reveals humanized H24 CD72 nanoCARs have unique transcriptional programs compared to CD19 CAR T cells. We further find that H24 nanoCARs lead to sustained CD72 downregulation on tumors treated in vivo. Underpinning this improved potency, H24 had higher binding affinity to CD72 compared to a fully llama framework. Further affinity maturation moderately increased cytotoxicity versus antigen-low tumors. This work supports clinical translation of H24 CD72 nanoCARs, reveals potential mechanisms of resistance to this cellular therapy, and unexpectedly demonstrates that nanoCAR potency can be improved by framework alterations alone, without any change to the complementarity determining regions (CDRs) of the nanobody sequence.

2022-12-29 | GSE218791 | GEO

Expression analysis in parthenogenetic cells through different potency stages

Project description:Parthenogenetic stem cells were derived from parthenotes, then differentiated to mesenchymal stem cells. These were further reprogrammed to induced pluripotent stem cells, which were finally differentiated to secondary mesenchymal stem cells. Transcriptional analysis was performed at all 4 states of potency to indetify changes in expression stability of partehnogenetic cells. 4 samples for each stage of potency were analyzed, controls were biparental embryonic stem cells and their mesenchymal derivate, as well as biparental induced pluripotent stem cells

2012-05-03 | E-GEOD-37711 | biostudies-arrayexpress

Solid phase chemistry to covalently and reversibly capture thiolated RNA

Project description:Here, we describe an approach to enrich newly transcribed RNAs from primary mouse neurons using 4-thiouridine (s4U) metabolic labeling and solid phase chemistry. This one-step enrichment procedure captures s4U-RNA by using highly efficient methane thiosulfonate (MTS) chemistry in an immobilized format. Like solution-based methods, this solid-phase enrichment can distinguish mature RNAs (mRNA) with differential stability, and can be used to reveal transient RNAs such as enhancer RNAs (eRNAs) and primary microRNAs (pri-miRNAs) from short metabolic labeling. Most importantly, the efficiency of this solid-phase chemistry made possible the first large scale measurements of RNA polymerase II (RNAPII) elongation rates in mouse cortical neurons. Thus, our approach provides the means to study regulation of RNA metabolism in specific tissue contexts as a means to better understand gene expression in vivo.

2018-07-19 | GSE110951 | GEO

Biomarkers for canine Leptospira vaccine potency

Project description:Biomarkers for canine Leptospira vaccine potency

| PRJNA793869 | ENA

High-depth spatial transcriptome analysis by photo-isolation chemistry

Project description:We established a transcriptome profiling method coupled with photo-isolation chemistry (PIC) that allows the determination of expression profiles specifically from photo-irradiated regions of interest.

2021-06-16 | GSE143413 | GEO

Differentiational potency of induced pluripotent stem cells into cardiomyocytes

2009-09-19 | GSE18117 | GEO

Human melanoma Cells (A2058): Control interference fragment transfected vs. PARP1 interference fragment transfected

Project description:Human melanoma Cells (A2058): Control interference fragment transfected vs. PARP1 interference fragment transfected

| PRJNA756736 | ENA

FOS Guards Quiescence and Potency in Human Hematopoietic Stem Cells [RNA-seq]

Project description:Quiescence and limited dividing are critical in preserving potency of hematopoietic stem/progenitor cell (HSPCs) during lifetime, but little is known about how this process is regulated. Here, we show that the mobilized human HSPCs in peripheral blood (PB) are predominantly in a quiescent state, but rapidly exit quiescence and reduce repopulating potency in short-term culture. Through single cell RNA-seq, we identified a panel of regulators highly associated with HSC quiescence exit and cell-cycle entry. These regulators involve different biological processes such as cell-cycle, signaling pathways, metabolisms, etc. Among them, the oncogene, FOS restrains cell-cycle entry and supports repopulating potency in human HSCs through directly binding and regulating genes both for HSC quiescence and potency. Our findings uncover the regulatory program underlying quiescence exit and highlight the critical role of FOS to guard the quiescence and potency in human HSPCs.

2021-06-08 | GSE176317 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data